NAII NATURAL ALTERNATIVES INTERNATIONAL INC

Nasdaq Medicinal Chemicals & Botanical Products DE CIK: 0000787253
AI RATING
STRONG_SELL
75% Confidence

Investment Thesis

Despite explosive revenue growth, the company exhibits severe operational distress with negative gross margins (4.2%), operating losses (-$2.5M), and deteriorating net income (-88.1% YoY). The company is burning cash operationally (-$10.4M) and lacks sufficient liquidity to sustain losses, with only $3.8M cash against $86.3M liabilities.

Strengths

  • + No long-term debt (Debt/Equity: 0.00x) reduces financial risk
  • + Decent current ratio of 1.87x provides short-term liquidity cushion
  • + Exceptional revenue growth at 14,292% YoY indicates potential market demand or successful business transformation

Risks

  • ! Negative free cash flow of -$12.3M indicates unsustainable operations requiring cash burn
  • ! Extremely thin gross margin of 4.2% suggests structural profitability challenges in manufacturing or pricing power
  • ! Net income declined 88.1% YoY despite massive revenue growth, indicating growth is non-profitable and destroys shareholder value
  • ! Operating cash flow deeply negative at -$10.4M signals core business cannot fund operations
  • ! Low cash reserves ($3.8M) relative to liabilities ($86.3M) provide minimal buffer for continued losses

Key Metrics to Watch

Financial Metrics

Revenue
32.7M
Net Income
-2.4M
EPS (Diluted)
$-0.41
Free Cash Flow
-12.3M
Total Assets
153.3M
Cash
3.8M

Profitability Ratios

Gross Margin 4.2%
Operating Margin -7.6%
Net Margin -7.3%
ROE -3.6%
ROA -1.6%
FCF Margin -37.7%

Balance Sheet & Liquidity

Current Ratio
1.87x
Quick Ratio
0.85x
Debt/Equity
0.00x
Debt/Assets
56.3%
Interest Coverage
-829.33x
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-13T00:24:22.897992 | Data as of: 2031-09-25 | Powered by Claude AI